The Nefertiti Lift: What Injecting Botox Along the Jaw and Into the Platysmal Bands Actually Does, Why the Name Oversells a Modest Effect, Who Is a Genuine Candidate, and Where the Technique's Ceiling Sits Before Surgery Becomes the Honest Answer

The Nefertiti lift is one of the better pieces of cosmetic branding in the last two decades, and that is precisely the problem with it. Queen Nefertiti's limestone bust, carved around 1345 BCE and now sitting in a Berlin museum, has a jaw that reads as sculpted: a clean, unbroken line from ear to chin with no shadow, no softness, and no visible muscle pulling against it. A cosmetic technique named after that bust promises the same thing from a syringe of neurotoxin and a few minutes in a treatment chair. What the procedure actually does is narrower and more mechanical than the name implies. It relaxes a specific muscle, the platysma, that runs from the collarbone up into the lower face and pulls the jawline down and the corners of the mouth with it. Weakening that pull can visibly sharpen a jaw that is being dragged on from below. It cannot build a jaw that bone and fat never gave a patient in the first place, and it is worth understanding the difference before booking the appointment.

This piece covers what the platysma actually does to a jawline and why relaxing it produces a lift without adding volume anywhere, the specific injection pattern that separates a well-done Nefertiti lift from a wasted syringe, what the technique can realistically achieve and the hard ceiling it runs into, who is a genuine candidate against who is paying for a treatment that cannot address their actual problem, and the risks that come from injecting neurotoxin this close to the muscles that control swallowing and smiling.

What the platysma actually does to a jawline, and why relaxing it produces a lift

The short answer: the platysma is a thin, sheet-like muscle running from the upper chest to the jaw and lower face, and in patients with strong or hyperactive platysmal tone it actively pulls the jawline and mouth corners downward, which means weakening it with neurotoxin can produce a visible lift without adding a single unit of volume anywhere on the face.

Most patients have never heard of the platysma until a cosmetic consultation, but it is doing more work on the aging jawline than almost any other single structure below the cheekbone. It sits directly under the skin of the neck and lower face, and unlike most facial muscles, which pull inward toward a fixed point, the platysma's fibers run vertically and its overall pull is downward, toward the collarbone. In a patient with strong platysmal tone, whether from genetics, habitual muscle use, or simply age-related hyperactivity of a muscle that no longer has as much overlying fat and skin to resist it, that downward pull actively drags on the jawline and the depressor muscles around the mouth. This is a mechanical tug-of-war, not just a cosmetic description: the platysma pulls down, and whatever bone, fat, and ligamentous support exists at the jaw pulls up, and the visible jawline is the net result of that contest. The piece on the aging neck and platysmaplasty covers this same muscle in its surgical context, where separated, banded platysma is treated with a corset repair rather than an injection, and the distinction between the two approaches is the entire subject of this piece.

Weakening an overactive puller with neurotoxin is a fundamentally different mechanism from filling a hollow with hyaluronic acid or fat, which is why the Nefertiti lift produces a result that looks like a lift rather than a fill. Botulinum toxin blocks the signal that tells the platysma to contract, and a platysma that contracts less pulls less. The jawline underneath does not change. The bone is the same bone, the fat pads are the same fat pads, and the skin has not been tightened by so much as a millimeter. What changes is the tension being applied against all of that from below, and in a patient whose main problem actually was an overactive platysma, removing that tension is enough to read, at a glance, as a sharper jaw and a smoother neck.

The injection pattern: why placement decides the result, not the total dose

The short answer: a well-executed Nefertiti lift places small doses of neurotoxin along the mandibular border and into the vertical platysmal bands rather than concentrating a large dose in one spot, and the pattern of placement, not the total unit count, is what separates a subtle, natural-reading lift from an over-treated, weak-looking lower face.

The technique, first described and popularized by Dutch physician Arjen Mookhoek in the mid-2000s, treats the jawline and upper neck as a single injection field rather than as isolated points. A typical pattern places several small injections along the inferior border of the jaw itself, weakening the platysma's insertion where it pulls hardest on the jawline, combined with additional injections down the visible vertical bands of the neck where they are most active on animation, the same bands addressed with neurotoxin alone in the piece on non-surgical double chin treatment and, in a more limited single-band sense, in the treatment approach mentioned as a partial fix in the piece on the aging neck and platysmaplasty. The doses at each point are deliberately small, typically two to four units per site across ten or more sites, because the goal is selective weakening of the downward pull rather than paralysis of the muscle sheet, which would flatten neck movement and look immediately unnatural.

This is where injector skill matters more than almost anywhere else neurotoxin is used on the face. The platysma sits directly beside and partially overlapping muscles that are not supposed to be touched: the depressor anguli oris and depressor labii, which control the corners and lower lip and are the same muscles treated deliberately, at a different dose and for a different purpose, in the piece on marionette lines and a downturned mouth, and the muscles of swallowing that sit just beneath the platysma in the neck. An injector who is trained specifically in this technique, rather than someone extrapolating from standard glabella or crow's feet training, is treating a three-dimensional pull with a two-dimensional injection map, and the piece on who is actually holding the needle is directly relevant here: this is a technique with a real learning curve, not a commodity injectable that any certified provider performs identically.

"

The Nefertiti lift is not a jaw filler and it is not a neck lift. It is a precise, low-dose weakening of one muscle's downward pull, and the entire result depends on whether the person holding the syringe understands exactly which fibers to target and which ones to leave alone.

"

What it can realistically achieve, and the hard ceiling it runs into

The short answer: the Nefertiti lift can produce a genuinely visible improvement in jawline definition and neck smoothness in the right patient, typically lasting three to four months in line with any neurotoxin treatment, but it cannot remove excess skin, cannot address a true fat deposit under the chin, and cannot reposition a jaw whose underlying bone and soft tissue have already descended.

In a patient with good skin elasticity, a reasonable amount of bone support at the jaw, and a platysma that is genuinely overactive rather than simply covering a deeper structural problem, the visible change can be substantial: a jawline that reads as blurred at rest can look distinctly sharper within one to two weeks, and the vertical cords that show on animation, the same cords addressed surgically in the piece on platysmaplasty, soften noticeably. The duration matches every other cosmetic use of botulinum toxin, meaning the muscle regains function and the pull returns within roughly three to four months, the same window covered generally in the piece on why Botox stops working and in the brand-specific duration comparison in the piece on Botox versus Dysport. This is a maintenance treatment, not a correction, and a patient who wants the result should plan on repeating it three to four times a year indefinitely.

The ceiling is where the marketing and the anatomy stop agreeing with each other. If the jawline blur is actually caused by a submental fat pad, the treatment does nothing to it, and the honest answer sits with the fat-specific options in the piece on double chin treatment or, for a defined pocket, the surgical option in the piece on masseter and jawline-adjacent contouring. If the blur is caused by loose, redundant skin that no longer retracts, weakening the muscle beneath it does not remove the excess, and can occasionally make loose skin look slightly more apparent once the muscle stops holding some tension against it. And if the jaw itself has genuinely descended, whether from bone remodeling, ligamentous laxity, or significant jowling, the piece on jawline contouring at forty and the piece on the aging neck both make the same point from different angles: no amount of muscle relaxation repositions tissue that has physically moved. The Nefertiti lift treats one variable in a jawline that usually has three or four working against it, and its honest ceiling is set by how much of the patient's actual problem is that one variable.

Who is a genuine candidate, and who is paying for the wrong treatment

The short answer: the strongest candidates are patients in their late thirties to early fifties with early platysmal banding, good skin quality, and a jawline blur that is caused by muscle pull rather than fat or excess skin, while patients with significant submental fat, loose neck skin, or advanced jowling are spending money on a treatment that cannot touch their actual anatomy.

A useful screening question, and one a good injector asks before ever loading a syringe, is whether the jawline blur and neck cords change meaningfully with muscle activation. Ask the patient to tense the neck, the same motion covered as a diagnostic in the piece on the aging neck, and if the cords become dramatically more prominent on tensing and largely disappear at rest, that is a muscle-driven pattern the Nefertiti lift is built for. If the jawline looks blurred and the cords look present even at complete rest, with little change on tensing, the problem is more likely fat, skin, or bony descent, and neurotoxin into the platysma is treating a muscle that was never the dominant cause. This distinction is the difference between a patient who is thrilled with a subtle, low-risk treatment and a patient who spends four hundred to eight hundred dollars every three months on a result she cannot actually see.

The risks of working this close to swallowing and smiling

The short answer: because the platysma sits directly adjacent to the muscles of the lower lip, the corner of the mouth, and the anterior neck involved in swallowing, the specific risks of the Nefertiti lift, beyond the ordinary bruising and swelling of any injectable, are an asymmetric or weakened smile, difficulty swallowing when toxin diffuses too deep or too medially in the neck, and a paradoxically worse jawline blur when too much muscle is weakened at once and the remaining skin loses what little tone it had.

An asymmetric smile is the most common complication reported with this technique, and it happens when neurotoxin intended for the platysma diffuses into the depressor anguli oris or depressor labii, the same muscles treated at a controlled, deliberate dose in the piece on marionette lines. Because those muscles sit in close proximity and share some functional overlap with the platysma at the jawline, an injector working without a precise map of where the platysma actually inserts can produce a mouth corner that drops rather than lifts, which is the opposite of the intended effect and can take the same three to four months to resolve as the treatment itself. Difficulty swallowing is rarer but more serious, and it results from toxin migrating too deep into the neck and affecting the strap muscles involved in swallowing mechanics rather than staying confined to the superficial platysma, which is one reason the dose-per-site in a proper Nefertiti lift stays low and the injections stay superficial rather than deep. And a genuinely paradoxical outcome, a jawline that looks slightly worse rather than better, can occur in a patient whose skin was already borderline for elasticity: removing the platysma's residual tone in a neck that had little structural support left can let already-loose skin settle rather than lift, which circles back to the same screening question raised earlier about whether the underlying cause is truly muscular.

None of this makes the Nefertiti lift a dangerous treatment in trained hands. Botulinum toxin itself has a long, well-documented safety record across facial and neck indications, including uses far more delicate than this one, covered in the piece on trapezius injections for shoulder and neck tension and the piece on excessive sweating treatment. The risk profile here is specifically about precision and anatomy, not about the drug, and it is a strong argument for choosing an injector on the basis of specific experience with this jawline and neck pattern rather than general comfort with neurotoxin. A rushed version of this treatment, squeezed in as an add-on before an event the way some patients approach the injectables covered in the piece on treatments before a big occasion, is exactly the scenario where the corner-of-the-mouth complication tends to show up.

The honest summary

The Nefertiti lift is a real, mechanistically sound treatment for a specific problem: a jawline and neck that are being actively pulled down by an overactive platysma in a patient who otherwise has decent skin and bone support. Done well, with small doses placed precisely along the jaw and into the vertical bands by an injector who actually understands this specific pattern, it produces a genuinely visible, natural-reading improvement that lasts three to four months before needing to be repeated. It does not remove fat, it does not tighten loose skin, and it does not reposition a jaw that has genuinely descended, which means a meaningful share of the patients drawn in by the name and the promise of a three-thousand-year-old queen's jawline are not actually candidates for what the injection can do. The tensing test, checked honestly in a mirror before booking, separates the two groups better than any amount of marketing copy, and the risks that do exist, an asymmetric smile most of all, are a direct function of how close this treatment works to muscles it is not supposed to touch. Ask what is actually pulling the jawline down before paying to weaken a muscle that may not be the one responsible.